| Patient | Katharine Hepburn |
|---|---|
| Date of birth | 1953-05-12 |
| Identifiers | MRN HR-ML012-SYN; SSN (made up) 000-12-8834 |
| Document date | 2026-08-04 |
| Author | Gwendolyn Price, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month tremor review. [S]
Ms. Hepburn returns six months after her first visit. She continues propranolol extended-release 60 mg each morning with no missed doses and no lightheadedness, wheeze, tiredness, or low mood. The hands remain steadier than in the winter; the head tremor is unchanged and does not trouble her. She uses the voice strategies on stage. She has had no falls. The occupational therapy evaluation that was to be booked after the last visit was not arranged, and it is now booked for two weeks from today. [S]
| Element | Detail |
|---|---|
| Medicine | Propranolol extended-release 60 mg daily; no side effects |
| Tremor | Hands steadier; head tremor unchanged |
| Falls | None in six months |
| Occupational therapy | Not yet seen; booked for two weeks from today |
| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Mild hand tremor and unchanged head tremor; no stiffness, slowness, or imbalance |
| Respiratory | Negative | No wheeze |
| Cardiovascular | Negative | No lightheadedness on standing or fainting |
| Psychiatric | Negative | Mood good |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Propranolol extended-release 60 mg oral capsule, one capsule by mouth once daily | One capsule by mouth each morning | Oral route | 2026-02-10 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-04 | Body height | 170 | cm | S |
| 2026-08-04 | Body weight | 56.3 | kg | S |
| 2026-08-04 | Body mass index (BMI) [Ratio] | 19.5 | kg/m2 | S |
| 2026-08-04 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-08-04 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-08-04 | Heart rate | 62 | /min | S |
| 2026-08-04 | Respiratory rate | 14 | /min | S |
| 2026-08-04 | Body temperature | 36.6 | Cel | S |
| 2026-08-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Vital signs recorded on 2026-08-04; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert and energetic |
| Cardiovascular | Regular rhythm at 62 per minute. Blood pressure 124/74 mmHg seated and 120/72 mmHg after 3 minutes standing, without symptoms; no orthostatic drop |
| Neurological | TETRAS performance subscale 15; daily-living subscale 8. Mild postural and kinetic hand tremor; head tremor unchanged; no rest tremor, bradykinesia, or rigidity; tandem gait normal |
| Gait | Steady; Timed Up and Go not repeated, due at the wellness visit |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Essential tremor: bilateral upper-limb action tremor with head (no-no) and voice tremor, without other neurological signs | active | provisional | G25.0 | S — Synthetic modern coding of her publicly visible tremor; the label is a retrospective interpretation (R), so verification is provisional. Severity scores are synthetic. |
| Voice tremor due to essential tremor, mild, with a wavering pitch on sustained vowels | active | confirmed | R49.8 | S — Synthetic modern coding anchored to public descriptions of her quivery voice; the severity at the index age is synthetic. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Tremor rating: TETRAS performance and activities of daily living subscales | Every visit | Completed today | Performance subscale 15; daily-living subscale 8 |
| Examination | Archimedes spiral drawing and handwriting sample | Every visit | Completed today | Small tremor waves; handwriting steady |
| Examination | Examination for signs beyond tremor (rest tremor, bradykinesia, rigidity, dystonia, ataxia, cognitive change) | At diagnosis, then yearly or with a change in the tremor | Up to date | No signs beyond tremor today; yearly neurology review due in the winter |
| Examination | Resting heart rate and seated and 3-minute standing blood pressure | Every visit on a beta-blocker | Completed today | Pulse 62; 124/74 mmHg seated and 120/72 mmHg standing; the standing check missed at three months was done today |
| Medication safety | Beta-blocker safety: wheeze, slow pulse or heart block, fatigue, cold hands, low mood, hypoglycemia awareness | Every visit | Completed today | No side effects |
| Medication safety | Primidone safety: sedation, unsteadiness, nausea | Every visit on primidone | Not indicated | Not on primidone |
| Medication safety | Drugs and substances that worsen tremor (beta-agonists, valproate, lithium, antidepressants, excess thyroid hormone, caffeine) | Every visit | Completed today | No new medicines |
| Examination | Fall query, with Timed Up and Go yearly | Every visit | Completed today | No falls in six months; Timed Up and Go due at the wellness visit |
| Survey | Mood (PHQ-9) | Before a beta-blocker, after starting it, then yearly | Up to date | PHQ-9 3 three months ago; mood good today |
| Laboratory | TSH and basic chemistry to exclude metabolic causes | Once at diagnosis; again only with a change in the tremor | Up to date | Normal at diagnosis |
| Referral | Speech-language therapy for voice tremor | When voice tremor affects speech or work | Up to date | Course completed; strategies in use |
| Referral | Occupational therapy for adaptive aids | When tremor limits daily tasks | Deferred | Recommended at the four-week visit but not booked for five months, a deviation from the plan. She managed by carrying cups half full and limiting writing, with no injury or loss of independence. Corrective action: the evaluation is booked for two weeks from today, and referrals are now tracked to completion |
| Medication safety | Botulinum toxin for head or voice tremor | If head or voice tremor is disabling | Not indicated | Head and voice tremor not disabling |
| Referral | Referral for focused ultrasound thalamotomy or deep brain stimulation | If disabling limb tremor persists after adequate trials of propranolol and primidone | Not indicated | Good response to propranolol; no disabling tremor |
| Survey | Cognitive screen (MoCA) | Yearly | Up to date | MoCA 28 seven months ago |
| Medication safety | AGS Beers Criteria medication review | Yearly from age 65 | Up to date | No new medicines |
| Self-management | Advance care planning and goals of care | At least yearly from 65 | Due | At the annual wellness visit in two months |
| Self-management | Vaccination status (influenza, pneumococcal, zoster, COVID-19, Tdap) | Yearly, per the CDC schedule | Due | Influenza, pneumococcal, and zoster vaccines at the wellness visit |
Goal progress:
Guideline basis: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2005); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018); MDS evidence-based review of treatments for essential tremor (2019); CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026)
Follow-up: Occupational therapy in two weeks. Annual wellness visit in two months. Tremor review in about six months. Next scheduled visit 2026-10-06: subsequent annual wellness visit. [S]